Publications

5600 Results

A phase III randomized study of nivolumab plus ipilimumab versus nivolumab for previously treated patients with stage IV squamous cell lung cancer and no matching biomarker (Lung-MAP Sub-Study S1400I, NCT02785952).

Authors
L Bazhenova;M Redman;S Gettinger;F Hirsch;PC Mack;L Schwartz;D Gandara;J Bradley;T Stinchcombe;N Leighl;S Ramalingam;S Tavernier;K Minichiello;K Kelly;V Papadimitrakopoulou;R Herbst
Journal / Conference
J Clin Oncol 37(suppl; abstr 9014); ASCO (5/31/19-6/4/19, Chicago IL), poster discussion
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1400I

Design and Accrual of SWOG S1417CD: Development of a Prospective Financial Impact Assessment Tool in Patients with Metastatic Colorectal Cancer (mCRC)

Authors
V Shankaran;J Unger;A Darke;JM Suga;JL Wade;P Kourlas;S Chandana;M O'Rourke;S Satti;D Liggett;D Hershman;S Ramsey
Journal / Conference
J Clin Oncol 37(suppl; abstr TPS6652); American Society of Clinical Oncology (5/31/19-6/4/19, Chicago IL), TIPS, poster session
Year
2019
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1417CD

S1507: Phase II study of docetaxel and trametinib in patients with G12C or non-G12C KRAS mutation positive (+) recurrent non-small cell lung cancer (NSCLC)

Authors
S Gadgeel;J Miao;J Riess;PC Mack;G Gerstner;TF Burns;A Taj;W Akerley;K Dragnev;J Moon;D Gandara;K Kelly
Journal / Conference
J Clin Oncol 37(suppl; abstr 9021); American Society of Clinical Oncology (5/31/19-6/4/19, Chicago IL), poster discussion
Year
2019
Research Committee(s)
Lung
Study Number(s)
S1507

SWOG S1505: Initial Findings on Eligibility and Neoadjuvant Chemotherapy Experience with mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Authors
D Sohal;D Lew;S Ahmad;N Gandhi;S Beg;A Wang-Gillam;J Wade;K Guthrie;A Lowy;P Philip;H Hochster
Journal / Conference
J Clin Oncol 37(suppl; abstr 4137); American Society of Clinical Oncology (5/31/19 - 6/4/19, Chicago IL), poster session
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

Randomized Phase II Study of 2nd Line Modified FOLFIRI with PARP Inhibitor ABT-888 (Veliparib) (NSC-737664) vs FOLFIRI in Metastatic Pancreatic Cancer (mPC): SWOG S1513

Authors
EG Chiorean;K Guthrie;PA Philip;E Swisher;F Jalikis;M Pishvaian;J Berlin;MS Noel;JM Suga;I Garrido-Laguna;D Cardin;D Lew;A Lowy;H Hochster
Journal / Conference
J Clin Oncol 37(suppl; abstr 4014); American Society of Clinical Oncology (5/31-6/4/19, Chicago IL), poster discussion
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
S1513

SWOG S1609: A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART)

Authors
S Patel;M Othus;Y Chae;F Giles;J Hayward;C McLeod;H Chen;E Sharon;E Mayerson;C Ryan;M Plets;CD Blanke;R Kurzrock
Journal / Conference
J Clin Oncol 37(suppl; abstr TPS2658); ASCO (5/31-6/4/2019, Chicago IL), TIPS, poster session
Year
2019
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Sex Differences in Adverse Event Reporting in SWOG Chemotherapy, Biologic/Immunotherapy and Targeted Agent Cancer Clinical Trials

Authors
JM Unger;R Vaidya;K Albain;M Leblanc;L Minasian;C Gotay;NL Henry;M Fisch;S Ramsey;CD Blanke;D Hershman
Journal / Conference
J Clin Oncol 37(suppl; abstr 11588); American Society of Clinical Oncology (5/31-6/4/2019, Chicago IL), poster session
Year
2019
Research Committee(s)
Cancer Care Delivery and Symptom Management and Survivorship

The Impact of NCI-Sponsored Network Group Clinical Trials on Guideline Care and New Drug Indications

Authors
J Unger;V Nghiem;DL Hershman;R Vaidya;M Leblanc;CD Blanke
Journal / Conference
J Clin Oncol 37(suppl; abstr 6604); American Society of Clinical Oncology (5/31-6/4/2019, Chicago IL), poster session
Year
2019
Research Committee(s)
Cancer Care Delivery

The Association of Baseline Cardiovascular Risk Factors and Healthcare Utilization and Costs in Elderly Breast Cancer Patients Enrolled in SWOG Clinical Trials

Authors
D Hershman;C Till;J Wright;M Accordino;R Vaidya;W Barlow;S Ramsey;J Unger
Journal / Conference
J Clin Oncol 37(suppl; abstr 11508); American Society of Clinical Oncology (5/31-6/4/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Cancer Care Delivery

Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202)

Authors
E Bergsland;M Mahoney;T Asmis;N Hall;P Kumthekar;M Maitland;D Niedzwiecki;AB Nixon;EM O'Reilly;LH Schwartz;JA Sloan;J Strosberg;J Meyerhardt
Journal / Conference
J Clin Oncol 37(suppl; abstr 4005); American Society of Clinical Oncology (5/31 - 6/4/2019, Chicago IL), oral
Year
2019
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/A021202